Curanex Pharmaceuticals Inc (NasdaqCM: CURX)
Health Care · Pharmaceuticals · US
$0.27
+24.38% today · -94.6% 1Y
Curanex Pharmaceuticals Inc (NasdaqCM: CURX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.17M and employs 6 people.
Over the last twelve months the share price has lost 94.6%, trading between 0.18 and 9.18.
Tweenvest scores Curanex Pharmaceuticals Inc across four factors: quality 39/100. Its strongest factor is quality.
CURX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.17M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.27
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $9.18
- 52-week low
- $0.18
- Avg volume (3M)
- —
- Shares outstanding
- 28.36M
- Employees
- 6
- Next earnings
- —
About Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
- Founded
- 1996
- Listed since
- Aug 26, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.